JPS5912097B2 - Method for producing cyclic compounds - Google Patents
Method for producing cyclic compoundsInfo
- Publication number
- JPS5912097B2 JPS5912097B2 JP5103474A JP5103474A JPS5912097B2 JP S5912097 B2 JPS5912097 B2 JP S5912097B2 JP 5103474 A JP5103474 A JP 5103474A JP 5103474 A JP5103474 A JP 5103474A JP S5912097 B2 JPS5912097 B2 JP S5912097B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- acid
- formula
- compound
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 150000001923 cyclic compounds Chemical class 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- WQADWIOXOXRPLN-UHFFFAOYSA-N 1,3-dithiane Chemical compound C1CSCSC1 WQADWIOXOXRPLN-UHFFFAOYSA-N 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 239000002904 solvent Substances 0.000 description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000000921 elemental analysis Methods 0.000 description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 14
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- -1 t -butyl esters Chemical class 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 239000013078 crystal Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 238000003797 solvolysis reaction Methods 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 238000001953 recrystallisation Methods 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 4
- JBQMFBWTKWOSQX-UHFFFAOYSA-N 2,3-dihydro-1h-indene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)CCC2=C1 JBQMFBWTKWOSQX-UHFFFAOYSA-N 0.000 description 3
- FXUBHWHRMVGJOG-UHFFFAOYSA-N 4-benzoyl-2,3-dihydro-1h-indene-1-carboxylic acid Chemical compound OC(=O)C1CCC2=C1C=CC=C2C(=O)C1=CC=CC=C1 FXUBHWHRMVGJOG-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 230000009435 amidation Effects 0.000 description 3
- 238000007112 amidation reaction Methods 0.000 description 3
- WIRUZQNBHNAMAB-UHFFFAOYSA-N benzene;cyclohexane Chemical compound C1CCCCC1.C1=CC=CC=C1 WIRUZQNBHNAMAB-UHFFFAOYSA-N 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 2
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 1
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- CXWGKAYMVASWDQ-UHFFFAOYSA-N 1,2-dithiane Chemical compound C1CCSSC1 CXWGKAYMVASWDQ-UHFFFAOYSA-N 0.000 description 1
- DOBUSJIVSSJEDA-UHFFFAOYSA-L 1,3-dioxa-2$l^{6}-thia-4-mercuracyclobutane 2,2-dioxide Chemical compound [Hg+2].[O-]S([O-])(=O)=O DOBUSJIVSSJEDA-UHFFFAOYSA-L 0.000 description 1
- LIUSHSVUMMYGRB-UHFFFAOYSA-N 1-naphthalen-1-yl-n-phenoxymethanamine Chemical compound C=1C=CC2=CC=CC=C2C=1CNOC1=CC=CC=C1 LIUSHSVUMMYGRB-UHFFFAOYSA-N 0.000 description 1
- YMWHOUYBOXFYCQ-UHFFFAOYSA-N 2,3-dihydro-1h-indene-1,4-dicarboxylic acid Chemical compound C1=CC=C(C(O)=O)C2=C1C(C(=O)O)CC2 YMWHOUYBOXFYCQ-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 1
- KRXAVBPUAIKSFF-UHFFFAOYSA-N 3,4-dihydrodithiine Chemical compound C1CC=CSS1 KRXAVBPUAIKSFF-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NKRPMEPOSOYHKB-UHFFFAOYSA-N 4-(4-chloro-3-methylbenzoyl)-2,3-dihydroinden-1-one Chemical compound C1=C(Cl)C(C)=CC(C(=O)C=2C=3CCC(=O)C=3C=CC=2)=C1 NKRPMEPOSOYHKB-UHFFFAOYSA-N 0.000 description 1
- MSSNFZVCPWFZHW-UHFFFAOYSA-N 4-(4-chlorobenzoyl)-2,3-dihydro-1h-indene-1-carboxylic acid Chemical compound OC(=O)C1CCC2=C1C=CC=C2C(=O)C1=CC=C(Cl)C=C1 MSSNFZVCPWFZHW-UHFFFAOYSA-N 0.000 description 1
- FDRLLMAFDMQAJY-UHFFFAOYSA-N 4-(4-chlorobenzoyl)-2,3-dihydroinden-1-one Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC=CC2=C1CCC2=O FDRLLMAFDMQAJY-UHFFFAOYSA-N 0.000 description 1
- WZAJBIXBRFTJRC-UHFFFAOYSA-N 4-(4-methylbenzoyl)-2,3-dihydro-1h-indene-1-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC2=C1CCC2C(O)=O WZAJBIXBRFTJRC-UHFFFAOYSA-N 0.000 description 1
- GREYVSOWISPLEK-UHFFFAOYSA-N 4-(4-methylbenzoyl)-2,3-dihydroinden-1-one Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC2=C1CCC2=O GREYVSOWISPLEK-UHFFFAOYSA-N 0.000 description 1
- GZCHRCOKOCGWHP-UHFFFAOYSA-N 4-benzoyl-2,3-dihydro-1h-indene-1-carboxamide Chemical compound NC(=O)C1CCC2=C1C=CC=C2C(=O)C1=CC=CC=C1 GZCHRCOKOCGWHP-UHFFFAOYSA-N 0.000 description 1
- BAZOIHGIIQZVEN-UHFFFAOYSA-N 4-benzoyl-2,3-dihydroinden-1-one Chemical compound C=1C=CC=2C(=O)CCC=2C=1C(=O)C1=CC=CC=C1 BAZOIHGIIQZVEN-UHFFFAOYSA-N 0.000 description 1
- LSTIJBHZBDPZQD-UHFFFAOYSA-N 5-(4-chlorobenzoyl)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid Chemical compound OC(=O)C1CCCC2=C1C=CC=C2C(=O)C1=CC=C(Cl)C=C1 LSTIJBHZBDPZQD-UHFFFAOYSA-N 0.000 description 1
- RTAVKLHNGTYGGE-UHFFFAOYSA-N 5-(4-chlorobenzoyl)-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC=CC2=C1CCCC2=O RTAVKLHNGTYGGE-UHFFFAOYSA-N 0.000 description 1
- UQKDDVYIARQBJM-UHFFFAOYSA-N 5-(4-methylbenzoyl)-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=CC2=C1CCCC2C(O)=O UQKDDVYIARQBJM-UHFFFAOYSA-N 0.000 description 1
- AJVCRFSGWFAACQ-UHFFFAOYSA-N 5-benzoyl-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid Chemical compound OC(=O)C1CCCC2=C1C=CC=C2C(=O)C1=CC=CC=C1 AJVCRFSGWFAACQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FLZLQOUAQAKEBF-UHFFFAOYSA-N CC1=C(C=CC(=C1)C(=O)C2=CC=CC3=C2CCC3C(=O)O)Cl Chemical compound CC1=C(C=CC(=C1)C(=O)C2=CC=CC3=C2CCC3C(=O)O)Cl FLZLQOUAQAKEBF-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- LOZWAPSEEHRYPG-UHFFFAOYSA-N dithiane Natural products C1CSCCS1 LOZWAPSEEHRYPG-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- PNPYIUOCYWNZJC-UHFFFAOYSA-N ethyl 4-benzoyl-2,3-dihydro-1h-indene-1-carboxylate Chemical compound CCOC(=O)C1CCC2=C1C=CC=C2C(=O)C1=CC=CC=C1 PNPYIUOCYWNZJC-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- DWNRISLZVCBTRN-UHFFFAOYSA-N lithium;piperidin-1-ide Chemical compound [Li]N1CCCCC1 DWNRISLZVCBTRN-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- NGYIMTKLQULBOO-UHFFFAOYSA-L mercury dibromide Chemical compound Br[Hg]Br NGYIMTKLQULBOO-UHFFFAOYSA-L 0.000 description 1
- 229910000370 mercury sulfate Inorganic materials 0.000 description 1
- SCTINZGZNJKWBN-UHFFFAOYSA-M mercury(1+);fluoride Chemical compound [Hg]F SCTINZGZNJKWBN-UHFFFAOYSA-M 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- PGGSYJMONFCBEJ-UHFFFAOYSA-N methyl 1-oxo-2,3-dihydroindene-4-carboxylate Chemical compound COC(=O)C1=CC=CC2=C1CCC2=O PGGSYJMONFCBEJ-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
- 229940067157 phenylhydrazine Drugs 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 125000005930 sec-butyloxycarbonyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- CGRKYEALWSRNJS-UHFFFAOYSA-N sodium;2-methylbutan-2-olate Chemical compound [Na+].CCC(C)(C)[O-] CGRKYEALWSRNJS-UHFFFAOYSA-N 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は医薬として有用な一般式
〔式中、nは1または2の整数を、Aはカルボキシル基
、低級アルコキシカルボニル基または置換基として低級
アルキルまたはハロゲン原子を有していてもよいベンゾ
イル基を示す。DETAILED DESCRIPTION OF THE INVENTION The present invention provides a pharmaceutically useful general formula [where n is an integer of 1 or 2, and A has a carboxyl group, a lower alkoxycarbonyl group, or a lower alkyl or halogen atom as a substituent] Indicates an optional benzoyl group.
〕で表わされる新規環状化合物の製造法に関する。さら
に詳しくは、本発明は、
(1) 一般式
〔式中、nおよびAは前記と同意義。] This invention relates to a method for producing a novel cyclic compound represented by: More specifically, the present invention has the following features: (1) General formula [wherein n and A have the same meanings as above.
〕で表わされる化合物を水または低級脂肪族アルコール
の存在下に加溶媒分解することを特徴とする前記一般式
〔1〕で表わされる化合物の製造法(2) 一般式
〔式中、nおよびAぱ前記と同意義。Method for producing a compound represented by the general formula [1] (2), which comprises solvolyzing the compound represented by the general formula [1] in the presence of water or a lower aliphatic alcohol. Same meaning as above.
〕で表わされる化合物と1・3−ジチアンを塩基の存在
下で反応させ、生成する一般式〔式中、nおよびAは前
記と同意義。] A compound represented by the general formula [where n and A have the same meanings as above] is produced by reacting a compound represented by the following with 1,3-dithiane in the presence of a base.
〕で表わされる化合物を脱水し、生成する前記一般式〔
〕で表わされる化合物を水または低級脂肪族アルコール
の存在下に加溶媒分解することを特徴とする前記一般式
〔1〕で表わされる化合物の製造法である。前記一般式
〔1〕、〔〕、〔〕、〔〕中、Aで表わされるベンゾイ
ル基は、炭素数1〜4程度の直鎖または分枝した低級ア
ルキル基(例、メチル、エチル、プロピル、イソプロピ
ル、ブチル、イソブチル、Sec−ブチル、t−ブチル
基)、ハロゲン原子(例、フツ素、塩素、臭素、ヨウ素
原子)を置換基として有していてもよく、これらの置換
基は1または2個、同一または異なつて、ベンゾイル基
の任意の位置に置換していてもよい。] The compound represented by the above general formula [
This is a method for producing a compound represented by the general formula [1], which comprises solvolyzing the compound represented by the formula [1] in the presence of water or a lower aliphatic alcohol. In the general formula [1], [], [], [], the benzoyl group represented by A is a linear or branched lower alkyl group having about 1 to 4 carbon atoms (e.g., methyl, ethyl, propyl, isopropyl, butyl, isobutyl, Sec-butyl, t-butyl group), halogen atom (e.g., fluorine, chlorine, bromine, iodine atom) as a substituent, and these substituents have 1 or 2 The benzoyl group may be substituted at any position of the benzoyl group, individually, the same or different.
また、前記一般式〔1〕、〔〕、〔〕、〔〕においてR
で示される低級アルコキシカルボニル基としては、たと
えばメトキシカルボニル、エトキシカルボニル、プロポ
キシカルボニル、イソプロポキシカルボニル、ブトキシ
カルボニル、イソブトキシカルボニル、Sec−ブトキ
シカルボニル、t−プトキシカルボニルなどがあげられ
る。Furthermore, in the general formula [1], [], [], [], R
Examples of the lower alkoxycarbonyl group represented by include methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, isobutoxycarbonyl, Sec-butoxycarbonyl, t-ptoxycarbonyl, and the like.
また、前記一般式〔1〕においてRで示されるアルキル
基としては、たとえばメチル、エチル、プロピル、イソ
プロピル、ブチル、イソブチル,、Sec−ブチル、t
−ブチルエステルなどがあげられる。前記一般式〔〕で
表わされる化合物は、下記〔a〕、〔b〕の2種の構造
をとり得るものであり、そのいずれも本発明の加溶媒分
解に供することができるが、とりわけ〔a〕の構造のも
のが好都合に用いられる。In addition, examples of the alkyl group represented by R in the general formula [1] include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, Sec-butyl, t
-butyl esters, etc. The compound represented by the above general formula [] can have two types of structures, [a] and [b] below, and either of them can be subjected to the solvolysis of the present invention, but especially [a] ] is conveniently used.
〔式中、nおよびAは前記と同意義。[In the formula, n and A have the same meanings as above.
〕本発明においては一般式〔〕の化合物を加溶媒分解(
SOlvOlysis)して一般式〔1〕の化合物ノを
得る。] In the present invention, the compound of the general formula [ ] is subjected to solvolysis (
SolvOlysis) to obtain a compound of general formula [1].
加溶媒分解としては、水を溶触として用いる加水分解、
低級脂肪族アルコール類(例、メタノール、エタノール
、プロパノール、イソプロパノール、ブタノール、イソ
ブタノール、Sec−ブタノール、t−ブタノールなど
)を溶媒として用いる加アルコール分解などが一般的で
ある。加溶媒分解は一般式に触媒の存在下に行なわれ、
触媒としてはたとえばハロゲン化水素(例、塩化水素、
臭化水素、ヨウ化水素など)、硫酸、リン酸、ポリリン
酸などの鉱酸;ギ酸、酢酸、パラトルエンスルホン酸、
β−ナフタリンスルホン酸などの有機酸,重金属の塩(
例、塩化水銀、臭化水銀、弗化水銀、硫酸水銀、塩化銅
、臭化銅など)などが用いられる。これらの触媒は単独
で用いる場合もあるし、二つ以上を同時に用いる場合も
ある。反応温度は使用溶媒、触媒などの反応条件により
異なるが一般に冷却下、室温、加熱下のいずれでもよい
。反応時間に特に限定はない。生成物〔1〕におけるB
は加溶媒分解の条件により多少異なり、反応条件を選定
することにより意図するBを有する目的化合物を得るこ
とができる。たとえば化合物〔〕を加水分解した場合に
は生成物〔〕としてRが水素原子である化合物が得られ
る。また、化合物〔〕を加アルコール分解した場合には
生成物〔1〕としてBが使用した低級脂肪族アルコール
に対応する低級アルキル基である化合物が得られる。ま
た上記加溶媒分解の工程の反応条件を選定することによ
り化合物〔〕のAで示される基がエステル化もしくは脱
エステル化された形の目的化合物〔1〕を得ることもで
きる。前記した化合物〔〕は、たとえば前記一般式〔〕
の化合物から有利に製造される。Solvolysis includes hydrolysis using water as a molten catalyst,
Alcoholycolysis using lower aliphatic alcohols (eg, methanol, ethanol, propanol, isopropanol, butanol, isobutanol, Sec-butanol, t-butanol, etc.) as a solvent is common. Solvolysis is generally carried out in the presence of a catalyst,
Examples of catalysts include hydrogen halides (e.g., hydrogen chloride,
(hydrogen bromide, hydrogen iodide, etc.), mineral acids such as sulfuric acid, phosphoric acid, polyphosphoric acid; formic acid, acetic acid, para-toluenesulfonic acid,
Organic acids such as β-naphthalene sulfonic acid, heavy metal salts (
For example, mercury chloride, mercury bromide, mercury fluoride, mercury sulfate, copper chloride, copper bromide, etc.) are used. These catalysts may be used alone or in combination of two or more. The reaction temperature varies depending on the reaction conditions such as the solvent and catalyst used, but generally it may be under cooling, at room temperature, or under heating. There is no particular limitation on the reaction time. B in product [1]
varies somewhat depending on the solvolysis conditions, and the target compound having the intended B can be obtained by selecting the reaction conditions. For example, when a compound [ ] is hydrolyzed, a compound in which R is a hydrogen atom is obtained as a product [ ]. Furthermore, when the compound [] is subjected to alcoholysis, a compound in which B is a lower alkyl group corresponding to the lower aliphatic alcohol used is obtained as the product [1]. Furthermore, by selecting the reaction conditions of the above-mentioned solvolysis step, it is also possible to obtain the target compound [1] in which the group represented by A of the compound [] is esterified or de-esterified. The above-mentioned compound [] is, for example, the above-mentioned general formula []
is advantageously prepared from a compound of
すなわち、本発明は、化合物〔〕から目的化合物〔1〕
を工業的に有利に製造する方法をも提供するものでもあ
る。本方法においては、まず化合物〔〕と1・3−ジチ
アンとが塩基の存在下に反応させられる。塩基としては
、たとえばアルカリ金属の水酸化物(例、水酸化ナトリ
ウム、水酸化カリウムなど)、アルカリ金属の水素化物
(例、水素化ナトリウム、水素化リチウムなど)、アル
カリ金属のアルコラード(例、ナトリウムメチラート、
ナトリウムエチラート、ナトリウムt−ブチラート、カ
リウムt−ブチラート、ナトリウムt−アミラートなど
)、アルカリ金属のアミド(例、ナトリウムアミド、カ
リウムアミド、リチウムアミド、ナトリウムピペリジド
、カリウムピペリジド、リチウムピペリジド、ナトリウ
ムジエチルアミド、カリウムジエチルアミド、リチウム
ジエチルアミド、ナトリウムジイソプロピルアミド、カ
リウムジイソプロピルアミド、リチウムジイソプロピル
アミド、リチウムビストリメチルシリルアミド、リチウ
ムジシクロヘキシルアミドなど)、n−ブチルリチウム
、トリトン−Bなどがあげられる。本反応は一般に溶媒
の存在下に行なわれ、溶媒としては、反応に不活性なも
のであれば特に限定されないが、たとえばエーテル類(
例、ジエチルエーテル、テトラヒドロフラン、ジオキサ
′/, 1・2−ジメトキシエタン、1・2−ジエトキ
シエタン、ジエチレングリコールジメチルエーテルなど
)ベンゼン、トルエン、キシレン、水などが好都合に用
いられる。反応に用いられる1・3−ジチアンおよび塩
基の量に特に限定はないが、化合物〔〕1モル当りそれ
ぞれ約1〜2.0モル程度が好ましい。また反応温度は
約−30℃〜溶媒の沸点程度、反応時間は約5〜25時
間程度が好ましい〜
かくして生成する一般式〔〕の化合物を脱水することに
より前記一般式〔〕の化合物を得ることができる。That is, the present invention provides a method for converting a compound [] to a target compound [1]
It also provides an industrially advantageous method for manufacturing. In this method, first, the compound [] and 1,3-dithiane are reacted in the presence of a base. Examples of bases include alkali metal hydroxides (e.g., sodium hydroxide, potassium hydroxide, etc.), alkali metal hydrides (e.g., sodium hydride, lithium hydride, etc.), alkali metal alcoholades (e.g., sodium methylate,
sodium ethylate, sodium t-butyrate, potassium t-butyrate, sodium t-amylate, etc.), amides of alkali metals (e.g., sodium amide, potassium amide, lithium amide, sodium piperidide, potassium piperidide, lithium piperidide) n-butyllithium, triton-B, and the like. This reaction is generally carried out in the presence of a solvent, and the solvent is not particularly limited as long as it is inert to the reaction, such as ethers (
For example, diethyl ether, tetrahydrofuran, dioxa'/, 1,2-dimethoxyethane, 1,2-diethoxyethane, diethylene glycol dimethyl ether, etc.) Benzene, toluene, xylene, water, etc. are advantageously used. The amounts of 1,3-dithiane and base used in the reaction are not particularly limited, but are preferably about 1 to 2.0 mol each per 1 mol of compound []. Further, the reaction temperature is preferably about -30°C to the boiling point of the solvent, and the reaction time is preferably about 5 to 25 hours. By dehydrating the thus produced compound of general formula [], the compound of general formula [] can be obtained. I can do it.
本反応に用いる化合物〔〕は常法によつて単離精製した
ものを用いることもできるが、前工程の反応液から単離
精製することなく本反応に供することもできる。本反応
に用いる脱水剤としては、たとえば鉱酸(例、硫酸、燐
酸、亜燐酸、塩酸など)、オキシ塩化燐、塩化チオニル
、アリールスルホン酸(例、ベンゼンスルホン酸、パラ
トルエンスルホン酸、β−ナフタリンスルホン酸など)
、酢酸およびその誘導体(例、トリフルオロ酢酸、トリ
クロロ酢酸など)、低級アルキルスルホン酸(例、メタ
ンスルホン酸、エタンスルホン酸、プロパンスルホン酸
など)などが好都合に用いられる。またこの時用いる液
媒は反応に支障のない限り特に限定はない。反応温度は
冷却下〜約150℃程度であり、反応時間等に限定はな
い。かくして生成する化合物〔〕を前記した加溶媒分解
反応に付すことにより目的化合物〔〕が得られる。The compound [] used in this reaction can be isolated and purified by a conventional method, but it can also be used in this reaction without being isolated and purified from the reaction solution of the previous step. Examples of dehydrating agents used in this reaction include mineral acids (e.g., sulfuric acid, phosphoric acid, phosphorous acid, hydrochloric acid, etc.), phosphorous oxychloride, thionyl chloride, arylsulfonic acids (e.g., benzenesulfonic acid, p-toluenesulfonic acid, β- naphthalene sulfonic acid, etc.)
, acetic acid and its derivatives (eg, trifluoroacetic acid, trichloroacetic acid, etc.), lower alkylsulfonic acids (eg, methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, etc.), and the like are advantageously used. Further, the liquid medium used at this time is not particularly limited as long as it does not interfere with the reaction. The reaction temperature is about 150° C. under cooling, and there are no limitations on the reaction time and the like. The target compound [] is obtained by subjecting the thus produced compound [] to the above-described solvolysis reaction.
本反応の場合も、化合物〔〕は常法によつて単離したも
のを用いることもできるが、前程の反応液から単離精製
することなく本反応に供することもできる。なお前記し
た化合物〔]と1・3−ジチアンとを反応させて化合物
〔〕を得る工程において、化合物〔〕が脱水されて一挙
に化合物〔〕が得られることもあり、また化合物〔〕を
脱水して化合物〔〕を得る工程において、生成する化合
物〔〕が加溶媒分解されて一挙に目的化合物〔1〕が得
られることもある。In the case of this reaction as well, the compound [] can be isolated by a conventional method, but it can also be used in this reaction without being isolated and purified from the previous reaction solution. In addition, in the step of reacting the compound [] with 1,3-dithiane to obtain the compound [], the compound [] may be dehydrated to obtain the compound [] all at once, or the compound [] may be dehydrated. In the step of obtaining the compound [], the generated compound [] may be solvolyzed to obtain the target compound [1] all at once.
かくしで生成する一般式〔1〕の化合物が遊離のカルボ
ン酸として得られる場合には、必要により、自体公知の
処理方法(例、中和等による塩の形成、酸の存在下にア
ルコールを用いるエステル化、アミンと反応させるアミ
ド化、酸ハライドに導いたのちアミンと反応させるアミ
ド化など)により、これをそのカルボキシル基における
誘導体に導いてもよく、逆にカルボキシル基における誘
導体を自体公知の処理方法(例、アルカリまたは酸の存
在下での加水分解)により、遊離のカルボン酸に導くこ
ともできる。When the compound of general formula [1] produced by hiding is obtained as a free carboxylic acid, if necessary, it may be treated by a known treatment method (e.g., formation of a salt by neutralization, etc., using alcohol in the presence of an acid). This may be converted into a derivative at the carboxyl group by esterification, amidation by reacting with an amine, amidation by converting it into an acid halide and then reacting with an amine, etc.), or conversely, the derivative at the carboxyl group can be converted into a derivative at the carboxyl group by a process known per se. Methods (eg hydrolysis in the presence of alkalis or acids) can also lead to the free carboxylic acids.
また、カルボキシル基における誘導体を自体公知の手段
(例、エステルにアミンを反応させるアミド化など)に
より、他の誘導体に導くこともできる。これらのカルボ
キシル基における誘導体の例としては、前記エステルの
ほかに、無置換アミド、置換アミド、塩などがあげられ
る。置換アミドとしては、ヒドロキサム酸(−CONH
OH)、ヒドラジド(−CONIINH2)、あるいは
アルキル部分が水酸基で置換されていてもよい炭素数1
〜3程度のモノまたはジ低級アルキルアミン(例、エタ
ノールアミン、ジエタノールアミン、メチルアミン、ジ
メチルアミン、エチルアミン、ジエチルアミン、プロピ
ルアミンなど)、アリールアミン(例、アニリン、メチ
ルアニリンなど)、1〜2個の窒素原子を有する5〜6
員環の環状アミン(例、モルホリン、ピロリジン、ピペ
リジン、ピペラジン、N一置換ピペラジンなど)、N−
アラルキル置換アミン(例、ベンジルアミン、α−メチ
ルベンジルアミン、フエネチルアミンなど)、アルキル
置換またはアリール置換ヒドラジン(例、メチルヒドラ
ジン、ジメチルヒドラジン、フエニルヒドラジンなど)
などの有機アミン類に対応するN−モノまたは置換アミ
ドなどがあげられる。Further, the derivative at the carboxyl group can be led to other derivatives by means known per se (for example, amidation in which an ester is reacted with an amine). Examples of derivatives of these carboxyl groups include, in addition to the above-mentioned esters, unsubstituted amides, substituted amides, salts, and the like. Substituted amides include hydroxamic acid (-CONH
OH), hydrazide (-CONIINH2), or a carbon number 1 in which the alkyl moiety may be substituted with a hydroxyl group
~3 mono- or di-lower alkylamines (e.g., ethanolamine, diethanolamine, methylamine, dimethylamine, ethylamine, diethylamine, propylamine, etc.), arylamines (e.g., aniline, methylaniline, etc.), 1 to 2 5-6 with nitrogen atom
membered cyclic amines (e.g., morpholine, pyrrolidine, piperidine, piperazine, N-monosubstituted piperazine, etc.), N-
Aralkyl-substituted amines (e.g., benzylamine, α-methylbenzylamine, phenethylamine, etc.), alkyl- or aryl-substituted hydrazines (e.g., methylhydrazine, dimethylhydrazine, phenylhydrazine, etc.)
Examples include N-mono or substituted amides corresponding to organic amines such as.
塩としては、たとえばアリカリ金属(例、ナトリウム、
力リウム、リチウムなど)、アルカリ土類金属(例、カ
ルシウム、マグネシウムなど)、アルミニウムなどの金
属との塩、アンモニウム塩、前記の有機アミンとの塩な
どがあげられる。かくして得られた目的化合物は自体公
知の方法、たとえば蒸留、再結晶、カラムクロマトグラ
フイ一などで分離、精製することができる。以上述べて
きた方法により得られる一般式〔1〕の化合物は、分子
内の1位に不斉炭素を有するので、自体公知の方法によ
りそれぞれd体、l体の光学異性体に分割することがで
きる。Salts include, for example, alkali metals (e.g. sodium,
salts with metals such as alkaline earth metals (eg, calcium, magnesium, etc.), aluminum, ammonium salts, and salts with the above-mentioned organic amines. The target compound thus obtained can be separated and purified by methods known per se, such as distillation, recrystallization, column chromatography, etc. Since the compound of general formula [1] obtained by the method described above has an asymmetric carbon at the 1-position in the molecule, it can be divided into d- and l-optical optical isomers by a method known per se. can.
すなわち、そのラセミ遊離酸を適当な不活性溶媒たとえ
ばクロロ1ホルム、アセトン、ベンゼン、ヘキサン、エ
ーテルなどに溶かし、光学的に活性な塩基と反応させ、
得られた塩あるいはアミドを、その溶解度の差によりジ
アステレオアイソマ一に分離し、つぎに酸で処理し遊離
のカルボン酸誘導体の光学活性体を単離することができ
る。またラセミの遊離酸と適当な光学活性アルコールか
ら、エステルを作り、このエステルをたとえば再結晶、
蒸留、クロマトグラフイ一などの自体公知の方法でジア
ステレオアイソマ一に分離し、つぎにエステルを酸また
は塩基の存在下加水分解しても、光学活性な遊離のカル
ボン酸誘導体を単離することができる。ここで用いる光
学活性な塩基としては、たとえばキニン、ブルシン、シ
ンコニジン、シンコニン、デヒドロアビチチルアミン、
ヒドロキシヒドリンダミン、タンチルアミン、モルピン
、α−フエニルヱチルアミン、フエニルオキシナフチル
メチルアミン、キニデン、ストイキニンなどのアミン、
リジン、アルギニンなどの塩基性アミノ酸、アミノ酸の
エステルなどがある。また光学活性なアルコールとして
は、たとえばボルネオール、メントール、2−オクタノ
ールなどがあげられる。以上述べたような光学分割で得
られた一般式〔1〕の化合物は、前述したような自体公
知の方法により、そのカルボキシル基における光学活性
な誘導体に導くことができる。本発明の方法によつて製
造される一般式〔〕の化合物およびそのカルボキシル基
における誘導体、とりわけAが置換基と・して低級アル
キル、ハロゲン原子を有していてもよいベンゾイル基で
あるものは顕著な消炎、鎮痛、解熱作用などを有し、た
とえば消炎剤、鎮痛剤、解熱剤などの医薬として有用で
ある。That is, the racemic free acid is dissolved in a suitable inert solvent such as chloro1form, acetone, benzene, hexane, ether, etc., and reacted with an optically active base.
The obtained salt or amide can be separated into diastereoisomers depending on their solubility, and then treated with an acid to isolate the optically active form of the free carboxylic acid derivative. Alternatively, an ester is prepared from a racemic free acid and a suitable optically active alcohol, and this ester is, for example, recrystallized.
Optically active free carboxylic acid derivatives can be isolated by separating diastereoisomers by methods known per se such as distillation or chromatography, and then hydrolyzing the ester in the presence of an acid or base. be able to. The optically active base used here includes, for example, quinine, brucine, cinchonidine, cinchonine, dehydroabititylamine,
Amines such as hydroxyhydrindamine, tantylamine, morpine, α-phenylethylamine, phenyloxynaphthylmethylamine, quinidene, stoikinine,
These include basic amino acids such as lysine and arginine, and amino acid esters. Examples of optically active alcohols include borneol, menthol, and 2-octanol. The compound of general formula [1] obtained by optical resolution as described above can be converted into an optically active derivative in its carboxyl group by a method known per se as described above. Compounds of the general formula [] and their carboxyl group derivatives produced by the method of the present invention, especially those in which A is a benzoyl group which may have a lower alkyl or halogen atom as a substituent, are It has remarkable anti-inflammatory, analgesic, and antipyretic effects, and is useful as a medicine such as an anti-inflammatory, analgesic, and antipyretic agent.
なおAがカルボキシル基あるいはそれから誘導される基
である場合は、フリーデルクラフト反応に付して、Aを
置換基として低級アルキル、ハロゲン原子を有していて
もよいベンゾイル基にかえることができる。本発明の目
的化合物をこれらの医薬として用いる場合の投与量は、
投与ルート、投与の目的などにより適宜選択されるが、
たとえば慢性関節リウマチ、変形性関節症、変形性を椎
症、関節痛、腰痛などを治療する目的で投与する場合は
、常用量として成人1日につき、約10〜100019
を錠剤、カプセル剤、散剤の適宜の剤型で経口的に投与
するか、あるいは成人1回量約5〜500!!19を注
射剤、坐剤などとして非経口的に投与するのがよい。When A is a carboxyl group or a group derived therefrom, A can be converted into a benzoyl group which may have a lower alkyl or halogen atom as a substituent by subjecting it to a Friedel-Crafts reaction. When the target compound of the present invention is used as these medicines, the dosage is as follows:
It is selected as appropriate depending on the administration route, purpose of administration, etc.
For example, when administered for the purpose of treating rheumatoid arthritis, osteoarthritis, osteoarthritis, spondylosis, arthralgia, low back pain, etc., the usual dose is approximately 10 to 100,019 ml per day for adults.
is administered orally in the appropriate dosage form of tablets, capsules, or powders, or in a single adult dosage of about 5 to 500! ! It is preferable to administer No. 19 parenterally as an injection, suppository, or the like.
以下に本発明を実施例によりさらに具体的に説明するが
、本発明がこれら実施例により限定されるものでないこ
とはいうまでもない。EXAMPLES The present invention will be explained in more detail with reference to Examples below, but it goes without saying that the present invention is not limited to these Examples.
実施例 1
(a) 1・3−ジチアン3.67を無水テトラヒドロ
フラン100m1に溶かし、窒素ガス気流中30℃に冷
却し、かき混ぜながらn−ブチルリチウムの20%ヘキ
サン溶液10m1を約15分かけて滴下する。Example 1 (a) 3.67 ml of 1,3-dithiane was dissolved in 100 ml of anhydrous tetrahydrofuran, cooled to 30°C in a nitrogen gas stream, and 10 ml of a 20% hexane solution of n-butyllithium was added dropwise over about 15 minutes while stirring. do.
滴下終了後同温度で2時間、続いて−5℃で30分かき
混ぜる。この溶液を再び−20゜Cに冷却しかき混ぜな
がら、7.17の4−ベンゾイルインダン一1−オンを
75m1の無水テトラヒドロフランに溶かした溶液を滴
下する。滴下終了後同温度で1時間かき混ぜたのち、O
℃で一夜放置する。次に減圧下溶媒を留去する。残留物
に希塩酸15m1を加えて工ーテルで抽出する。抽出層
は水、食塩水で洗い乾燥する。減圧下溶媒を留去して得
られた残留物はシリカゲルのカラムクロマトグラフイ一
(シルカゲル5007、ベンゼン一酢酸エチル20:1
の混合溶媒で溶出)で精製する。油状物として2−(4
−ベンゾイル一1−ヒドロキシ−1−インダニル)−1
・3−ジチアンが得られる。このものの赤外線吸収スペ
クトル(ニート)は1660c!n−1にケトンの吸収
、3450CTrL−1に水酸基による吸収を示し、構
造とよく一致する。(b) 2−(4−ベンゾイル−1
−ヒドロキシ−1ィンダニル)−1・3−ジチアン1.
47を300m1のベンゼンにとかし、600ηのパラ
トルエンスルホン酸を加える。After the addition was completed, the mixture was stirred at the same temperature for 2 hours and then at -5°C for 30 minutes. This solution was cooled again to -20°C, and while stirring, a solution of 7.17 4-benzoylindan-1-one dissolved in 75 ml of anhydrous tetrahydrofuran was added dropwise. After dropping, stir at the same temperature for 1 hour, then add O
Leave overnight at °C. Next, the solvent is distilled off under reduced pressure. Add 15 ml of dilute hydrochloric acid to the residue and extract with ether. The extracted layer is washed with water and saline and dried. The residue obtained by distilling off the solvent under reduced pressure was subjected to silica gel column chromatography (silica gel 5007, benzene monoethyl acetate 20:1).
(elution with a mixed solvent). As an oil, 2-(4
-benzoyl-1-hydroxy-1-indanyl)-1
- 3-dithiane is obtained. The infrared absorption spectrum (neat) of this product is 1660c! The absorption by ketone is shown at n-1, and the absorption by hydroxyl group is shown at 3450CTrL-1, which agrees well with the structure. (b) 2-(4-benzoyl-1
-hydroxy-1-indanyl)-1,3-dithiane1.
Dissolve 47 in 300 ml of benzene and add 600 η of para-toluenesulfonic acid.
脱水還流装置を使つて、脱水しながら、3時間還流する
。冷却後、水、炭酸水素ナトリウム水溶液、水で洗い乾
燥する。減圧下溶媒を留去すると、油状物として、2−
(4−ベンゾイル−1−インダニリデン)−1・3−ジ
チアンが得られる。このものは精製することなく次反応
に使用する。(c) 0.8fの2−(4−ベンゾイル
−1−インダニリデン)−1・3−ジチアンに150m
1の氷酢酸、5011tの濃塩酸を加え、3時間還流す
る。Reflux for 3 hours while dehydrating using a dehydrating reflux device. After cooling, wash with water, sodium bicarbonate aqueous solution, and water, and dry. When the solvent was distilled off under reduced pressure, 2-
(4-benzoyl-1-indanilidene)-1,3-dithiane is obtained. This product is used in the next reaction without purification. (c) 150m to 0.8f of 2-(4-benzoyl-1-indanilidene)-1,3-dithiane
Add 1 t of glacial acetic acid and 5011 t of concentrated hydrochloric acid, and reflux for 3 hours.
減圧下溶媒を留去し、残留物をエーテルで抽出する。エ
ーテル層は水洗したのち、5%の炭酸ナトリウム水溶液
で抽出する。抽出層はエーテルで洗つたのち、塩酸で酸
性にする。析出した油状物はエーテルで抽出する。抽出
層は水、食塩水で洗つたのち乾燥する。減圧下溶媒を留
去して得られた残留物はベンゼン−シクロヘキサン(7
:20)から結晶化する。融点100−102℃の結晶
として4−ベンゾイルインダン一1−カルボン酸が得ら
れる。元素分析値(Cl7Hl4O8)
計算値 C76.67;H5.3O
実験値 C76.37;H5.2l
上記で得られた4−ベンゾイルインダン一1−カルボン
酸3,2tとシンコニジン1.70rとをアセトン60
m1に加え、振り混ぜて溶かす。The solvent was distilled off under reduced pressure, and the residue was extracted with ether. After washing the ether layer with water, it is extracted with a 5% aqueous sodium carbonate solution. The extracted layer is washed with ether and then acidified with hydrochloric acid. The precipitated oil is extracted with ether. The extracted layer is washed with water and saline, and then dried. The residue obtained by distilling off the solvent under reduced pressure was diluted with benzene-cyclohexane (7
:20). 4-benzoylindane-1-carboxylic acid is obtained as crystals with a melting point of 100-102°C. Elemental analysis value (Cl7Hl4O8) Calculated value C76.67; H5.3O Experimental value C76.37; H5.2l 3.2t of 4-benzoylindane-1-carboxylic acid obtained above and 1.70r of cinchonidine were mixed in 60% acetone.
Add to m1 and shake to dissolve.
一夜室温に放置したのち析出結晶を▲取し、アセトンか
ら2回再結晶すると、(1)−4−ベンゾイルインダン
一1−カルボン酸のシンコニジン塩が融点189−19
2℃、〔α〕−132.28(C=1、CHCl3)の
無色結晶として得られる。After standing at room temperature overnight, the precipitated crystals were collected and recrystallized twice from acetone to obtain (1) cinchonidine salt of -4-benzoylindane-1-carboxylic acid with a melting point of 189-19.
Obtained as colorless crystals of [α]-132.28 (C=1, CHCl3) at 2°C.
元素分析値 C36H36O4N2
計算値 C77.l2;H6.47:N5.OO実験値
C77.l8:H6.28;N4.9l本品をクロロ
ホルムに溶かし、希塩酸で2回振り混ぜてシンコニジン
を除く。Elemental analysis value C36H36O4N2 Calculated value C77. l2;H6.47:N5. OO experimental value C77. 18: H6.28; N4.9l Dissolve this product in chloroform and shake twice with dilute hydrochloric acid to remove cinchonidine.
クロロホルム層を水洗後硫酸マグネシウムで乾燥する。
減圧下溶媒を留去すると(1)−4−ベンゾィルィンダ
ン一1−カルボン酸が〔α〕2式−66.4ィ(C=1
、MeOH)の無色油状物として得られる。元素分析値
C,7Hl4O3計算値 C76.67;H5.3O
実験値 C76.25;H5.37
最初の結晶を沢取した母液を減圧下濃縮し、残留物にシ
ンコニジン1.7tとアセトニトリル120m1とを加
えて加温下振り混ぜたのち一夜室温に放置する。The chloroform layer is washed with water and then dried with magnesium sulfate.
When the solvent was distilled off under reduced pressure, (1)-4-benzoylindane-1-carboxylic acid was converted to [α]2-66.4-(C=1
, MeOH) as a colorless oil. Elemental analysis value C,7Hl4O3 Calculated value C76.67; H5.3O Experimental value C76.25; H5.37 The mother liquor from which the first crystals were collected was concentrated under reduced pressure, and 1.7 t of cinchonidine and 120 ml of acetonitrile were added to the residue. Add to the mixture, shake while heating, and leave at room temperature overnight.
析出結晶を沢取し、アセトニトリルから3回再結晶する
と(d)−4−ベンゾイルインダン一1−カルボン酸の
シンコニジン塩が融点180−183℃、〔α〕2d1
1.2(C=1CHC13)の無色結晶として得られる
。元素分析値 C36C36O4N2
計算値 C77.l2;H6.47;N5.OO実験値
C77.l5;H6.42;N4.72本品をクロロ
ホルムに溶かし、希塩酸で2回振り混ぜてシンコニジン
を除く。The precipitated crystals were collected and recrystallized three times from acetonitrile to give (d) cinchonidine salt of -4-benzoylindane-1-carboxylic acid with a melting point of 180-183°C, [α]2d1
1.2 (C=1CHC13) as colorless crystals. Elemental analysis value C36C36O4N2 Calculated value C77. l2; H6.47; N5. OO experimental value C77. 15; H6.42; N4.72 Dissolve this product in chloroform and shake twice with dilute hydrochloric acid to remove cinchonidine.
クロロホルム層を水洗後硫酸マグネシウムで乾燥する。
減圧下溶媒を留去すると(d)−4−ベンゾイルインダ
ン一1−カルボン酸が〔α〕2d66.4ル(C=1、
MeOH)の無色油状物として得られる。元素分析値
Cl7Hl4O3計算値 C76.67;H5.3O
実験値 C76.53;H5.3O
(d) 6.6yの4−ベンゾイルインダン一1−カル
ボン酸に25m1の塩化チオニルを加え、一夜放置した
のち減圧下過量の塩化チオニルを留去する。The chloroform layer is washed with water and then dried with magnesium sulfate.
When the solvent was distilled off under reduced pressure, (d)-4-benzoylindane-1-carboxylic acid was obtained as [α]2d66.4l (C=1,
MeOH) as a colorless oil. Elemental analysis value
Cl7Hl4O3 Calculated value C76.67; H5.3O Experimental value C76.53; H5.3O (d) 25ml of thionyl chloride was added to 6.6y of 4-benzoylindane-1-carboxylic acid, and after standing overnight, the excess amount was determined under reduced pressure. thionyl chloride is distilled off.
残留物にエーテルを加えアンモニアガスを導入する。析
出した結晶を沢取し、水洗、乾燥したのちベンゼンから
再結晶する。4−ベンゾイルインダン一1−カルボン酸
アミドが融点164−166℃の結晶として得られる。Ether is added to the residue and ammonia gas is introduced. Collect a lot of the precipitated crystals, wash with water, dry, and then recrystallize from benzene. 4-benzoylindane-1-carboxylic acid amide is obtained as crystals with a melting point of 164-166°C.
元素分析値 Cl7Hl5O2N
計算値 C76.96;H5.7O;N5.28実験値
C76.78;H5.6l;N5.4l実施例 2実
施例1−bの方法によつて得た2−(4−ベンゾイル−
1−インダニリデン)−1・3−ジチアン2.0rをエ
タノール200m1に溶かし氷冷する。Elemental analysis value Cl7Hl5O2N Calculated value C76.96; H5.7O; N5.28 Experimental value C76.78; H5.6l; N5.4l Example 2 2-(4- benzoyl
Dissolve 2.0 liters of 1-indanilidene)-1,3-dithiane in 200 ml of ethanol and cool on ice.
この溶液に塩化水素ガスを15分間通じ、氷冷で2時間
つづいて、室温で一夜放置する。減圧下で過量の塩化水
素、溶媒を留去したのち水を加え、エーテルで抽出する
。抽出層は水洗後乾燥する。減圧下溶媒を留去して得ら
れた残留物をシリカゲルのカラムクロマトグラフイ一(
シリカゲル200P1溶出溶媒は2.5%の酢酸エチル
を含むベンゼン溶液)で精製する。4−ベンゾイルイン
ダン一1−カルボン酸エチルエステルが油状物として得
られる。Hydrogen chloride gas was passed through the solution for 15 minutes, followed by ice cooling for 2 hours, and then left overnight at room temperature. After distilling off excess hydrogen chloride and the solvent under reduced pressure, water was added and the mixture was extracted with ether. The extracted layer is washed with water and then dried. The residue obtained by distilling off the solvent under reduced pressure was subjected to silica gel column chromatography (
Silica gel 200P1 elution solvent is purified using a benzene solution containing 2.5% ethyl acetate. 4-benzoylindane-1-carboxylic acid ethyl ester is obtained as an oil.
元素分析値 ClOHl8O3
計算値 C77.53:H6.l6
実験値 C77.4l;H5.97
赤外線吸収スペクトル(ニート)
1720CTrL−1 (エステルのカルボニル)16
50CfL−1 (ケトンのカルボニル)実施例 31
・3−ジチアン3,67を無水テトラヒドロフラン10
0m1に溶かし、窒素ガス気流中−30℃に冷却し、か
き混ぜながらn−ブチルリチウムの20%ヘキサン溶液
10m1を約20分間かけて滴下する。Elemental analysis value ClOHl8O3 Calculated value C77.53:H6. l6 Experimental value C77.4l; H5.97 Infrared absorption spectrum (neat) 1720CTrL-1 (carbonyl of ester) 16
50CfL-1 (carbonyl of ketone) Example 31
・3-dithiane 3,67 in anhydrous tetrahydrofuran 10
The mixture was cooled to -30°C in a nitrogen gas stream, and 10 ml of a 20% hexane solution of n-butyllithium was added dropwise over about 20 minutes while stirring.
滴下終了後同温度で2時間、続いて−5℃で30分かき
混ぜる。この溶液を再び−20℃に冷却しかき混ぜなが
ら、8.17の4−(p−クロルベンゾイル)インダン
一1−オンを75m1の無水テトラヒドロフランに溶か
した溶液を滴下する。滴下終了後同温度で1時間かき混
ぜたのち、0℃で一夜放置する。次に減圧下で溶媒を留
去する。残留物に希塩酸を加えエーテルで抽出する。抽
出層は水、食塩水で洗つたのち乾燥する。減圧下溶媒を
留去して得られた残留物は精製することなく脱水反応を
付す。すなわち残留物を350m1のベンゼンに溶かし
、600ηのパラトルエンスルホン酸を加える。脱水還
流装置を使つて、脱水しながら3時間還流する。冷却後
、水、炭酸水素ナトリウム水溶液、水で洗う。減圧下溶
媒を留去して得た残留物は、精製することなく加水分解
する。残留物に150m1の氷酢酸、50m1の濃塩酸
を加え、3時間還流する。減圧下溶媒を留去し、残留物
に水を加え、エーテルで抽出する。エーテル層は水洗し
たのち、\%の炭酸ナトリウム水溶液で抽出する。抽出
層はエーテルで洗つたのち、塩酸で酸性にする。析出物
をクロロホルムで抽出し、抽出層は水洗したのち乾燥す
る。減圧下溶媒を留去して得られた残留物をベンゼン−
シクロヘキサン(3:10)から結晶化すると、融点1
37−139℃の結晶として、4−(p−クロルベンゾ
イル)インダン一1−カルボン酸が得られる。元素分析
値 Cl7Hl3O3Cl計算値 C67.89;H4
.36;Clll.79実験値 C67.6l;H4.
2l;Clll.9lノ上記で得られた4−(p−クロ
ルベンゾイノ(へ)インダン一1−カルボン酸3.1t
とシンコニン1.57とをアセトン100m1に加え、
加温して溶かしたのち少量の活性炭を加えて沢過する。After the addition was completed, the mixture was stirred at the same temperature for 2 hours and then at -5°C for 30 minutes. This solution is cooled again to -20 DEG C., and while stirring, a solution of 8.17 4-(p-chlorobenzoyl)indan-1-one dissolved in 75 ml of anhydrous tetrahydrofuran is added dropwise. After the addition was completed, the mixture was stirred at the same temperature for 1 hour, and then left at 0°C overnight. Next, the solvent is distilled off under reduced pressure. Dilute hydrochloric acid is added to the residue and extracted with ether. The extracted layer is washed with water and saline, and then dried. The residue obtained by distilling off the solvent under reduced pressure is subjected to a dehydration reaction without being purified. That is, the residue is dissolved in 350 ml of benzene and 600 η of para-toluenesulfonic acid are added. Using a dehydrating reflux device, reflux for 3 hours while dehydrating. After cooling, wash with water, aqueous sodium bicarbonate solution, and water. The residue obtained by distilling off the solvent under reduced pressure is hydrolyzed without purification. Add 150 ml of glacial acetic acid and 50 ml of concentrated hydrochloric acid to the residue, and reflux for 3 hours. The solvent was distilled off under reduced pressure, water was added to the residue, and the mixture was extracted with ether. After washing the ether layer with water, it is extracted with \% aqueous sodium carbonate solution. The extracted layer is washed with ether and then acidified with hydrochloric acid. The precipitate is extracted with chloroform, and the extracted layer is washed with water and then dried. The residue obtained by distilling off the solvent under reduced pressure was diluted with benzene.
When crystallized from cyclohexane (3:10), melting point 1
4-(p-chlorobenzoyl)indan-1-carboxylic acid is obtained as crystals at 37-139°C. Elemental analysis value Cl7Hl3O3Cl calculated value C67.89; H4
.. 36;Cll. 79 Experimental value C67.6l; H4.
2l; Clll. 9 liters of 4-(p-chlorobenzoino(he)indan-1-carboxylic acid obtained above) 3.1 t
and cinchonine 1.57 to 100 ml of acetone,
After heating and melting, add a small amount of activated charcoal and filter thoroughly.
▲液を一夜放冷し、さらに一夜0〜5℃に放置する。析
出結晶を沢取しアセトニトリルから再結晶すると(1)
−4−(p−クロルベンゾイル)インダン一1−カルボ
ン酸のシリコニン塩が融点193−196℃、〔α〕曾
33.6が(C=1、CHCl3)の無色結晶として得
られる。元素分析値 C36H34O4N2Cl
計算値 C72.78;H5.77;N4.72実験値
C72.5l;H5.92;N4.72本品をクロロ
ホルムに溶かし、希塩酸で2回振り混ぜてシンコニンを
除く。▲ Let the liquid cool overnight, and then leave it at 0-5°C overnight. When a lot of precipitated crystals are collected and recrystallized from acetonitrile, (1)
The siliconine salt of -4-(p-chlorobenzoyl)indan-1-carboxylic acid is obtained as colorless crystals with a melting point of 193-196°C and [α] of 33.6 (C=1, CHCl3). Elemental analysis value C36H34O4N2Cl Calculated value C72.78; H5.77; N4.72 Experimental value C72.5l; H5.92; N4.72 Dissolve this product in chloroform and shake twice with dilute hydrochloric acid to remove cinchonine.
クロロホルム層を水洗後硫酸マグネシウムで乾燥する。
減圧下溶媒を留去し残留物にシクロヘキサンを加えて生
じた結晶を沢取する。ベンゼンとシクロヘキサンとの混
液(1:4)から再結晶すると(1)−4−(p−クロ
ルベンゾイル)インダン一1−カルボン酸が融点121
−122℃、〔α〕M−66.9酸(C=1、MeOH
)の無色結晶として得られる。元素分析値 Cl7Hl
8O3Cl計算値 C67,89;H4.36
実験値 C67.72;H4.33
実施例 4
実施例3と同様の操作により、3.61の1・3−ジチ
アン、10m1f)n−ブチルリチウムの20%ヘキサ
ン溶液、7.57の4−(P−メチルベンゾイル)イン
ダン一1−オンから、4−(p−メチルベンゾイル)イ
ンダン一1−カルボン酸が得られる。The chloroform layer is washed with water and then dried with magnesium sulfate.
The solvent was distilled off under reduced pressure, cyclohexane was added to the residue, and the resulting crystals were collected. When recrystallized from a mixture of benzene and cyclohexane (1:4), (1)-4-(p-chlorobenzoyl)indan-1-carboxylic acid has a melting point of 121
-122℃, [α]M-66.9 acid (C=1, MeOH
) is obtained as colorless crystals. Elemental analysis value Cl7Hl
8O3Cl calculated value C67,89; H4.36 Experimental value C67.72; H4.33 Example 4 By the same operation as in Example 3, 20% of 3.61 1,3-dithiane, 10m1f) n-butyllithium 4-(p-Methylbenzoyl)indan-1-carboxylic acid is obtained from 7.57 4-(p-methylbenzoyl)indan-1-one in hexane solution.
融点129.5−131.0℃(再結晶溶媒:ベンゼン
ーシクロヘキサン8:25)元素分析値 C,8Cl6
O3
計算値 C77.l2;H5.75
実験値 C76.94;H5.6l
実施例 5
実施例3と同様の操作により、3.6Vの1・3ジチア
ン、10m1のn−ブチリルリチウムの20%ヘキサン
溶液、8.57の4−(p−クロルm−メチルベンゾイ
ル)インダン一1−オンから、4−(p−クロル−m−
メチルベンゾイル)インダン一1−カルボン酸が得られ
る。Melting point 129.5-131.0°C (Recrystallization solvent: benzene-cyclohexane 8:25) Elemental analysis value C,8Cl6
O3 calculated value C77. 12; H5.75 Experimental value C76.94; H5.6l Example 5 By the same operation as in Example 3, 3.6 V of 1.3 dithiane, 10 ml of a 20% hexane solution of n-butyryllithium, 8. 57 4-(p-chloro-m-methylbenzoyl)indan-1-one, 4-(p-chloro-m-
Methylbenzoyl)indan-1-carboxylic acid is obtained.
融点115.0−116.5℃(再結晶溶媒:ベンゼン
−シクロヘキサン3:20)元素分析値 Cl8Cl5
O3Cl
計算値 C68.68;H4.8O;Clll.27実
験値 C68.5l;H4.59;Clll.54実施
例 6
実施例3と同様の操作により、3.67の1・3−ジチ
アン、10m1f)n−ブチルリチウムの20%ヘキサ
ン溶液、7,5rの5−ベンゾリル一1−テトラロンか
ら、5−ベンゾイル−1・2・3・4−テトラヒトロー
1−ナフトエ酸が得られる。Melting point 115.0-116.5°C (Recrystallization solvent: benzene-cyclohexane 3:20) Elemental analysis value Cl8Cl5
O3Cl calculated value C68.68; H4.8O; Clll. 27 Experimental value C68.5l; H4.59; Clll. 54 Example 6 By the same operation as in Example 3, 5- Benzoyl-1,2,3,4-tetrahydro-1-naphthoic acid is obtained.
融点164−165℃(再結晶溶媒:ベンゼン)元素分
析値 Cl8Hl6O3
計算値 C77.l3;H5.75
実験値 C77.l5;H5.7O
実施例 7
実施例3と同様の操作により、3、6f7の1・3一ジ
チアン、10m1f)n−ブチルリチウムの20%ヘキ
サン溶液、7.91の5−(p−メチルベンゾイル)−
1−テトラロンから、5−(p−メチルベンゾイル)−
1・2・3・4−テトラヒトロー1−ナフトエ酸が得ら
れる。Melting point: 164-165°C (recrystallization solvent: benzene) Elemental analysis value: Cl8Hl6O3 Calculated value: C77. l3; H5.75 Experimental value C77. 15; H5.7O Example 7 By the same operation as in Example 3, 1,3-dithiane of 3,6f7, 20% hexane solution of n-butyllithium (10ml1f), 5-(p-methylbenzoyl of 7.91) )−
1-tetralone to 5-(p-methylbenzoyl)-
1,2,3,4-tetrahydro-1-naphthoic acid is obtained.
融点102−103℃(再結晶溶媒:シクロヘキサン)
元素分析値 Cl9Hl8O3
計算値 C77.53;H6.l6
実験値 C77.4l;H5.97
実施例 8
実施例3と同様の操作により、3.6Vの1・3一ジチ
アン、10me(l)n−ブチルリチウムの20%ヘキ
サン溶液、8.5f7の5−(p−クロルベンゾイル)
−1−テトラロンから、5−(p−クロルベンゾイル)
−1・2・3・4−テトラヒトロー1−ナフトエ酸が得
られる。Melting point 102-103℃ (recrystallization solvent: cyclohexane)
Elemental analysis value Cl9Hl8O3 Calculated value C77.53; H6. l6 Experimental value C77.4l; H5.97 Example 8 By the same operation as in Example 3, a 20% hexane solution of 3.6V 1.31 dithiane, 10me(l) n-butyllithium, and 8.5f7 5-(p-chlorobenzoyl)
-1-tetralone to 5-(p-chlorobenzoyl)
-1,2,3,4-tetrahydro-1-naphthoic acid is obtained.
融点152.5−153.5℃(再結晶溶媒:ベンゼン
ーヘキサン)元素分析値 Cl8Hl5O3Cl
計算値 C68.68;H4.8O:Clll.27実
験値 C68.75;H4.83;Clll。Melting point 152.5-153.5°C (recrystallization solvent: benzene-hexane) Elemental analysis value Cl8Hl5O3Cl Calculated value C68.68; H4.8O: Clll. 27 Experimental value C68.75; H4.83; Cllll.
25実施例 9
実施例3と同様の操作により、3.6yの1・3−ジチ
アン、10m1のn−ブチルリチウムの20%ヘキサン
溶液、5.3Vの1−オキソインダン一4−カルボン酸
メチルエステルから、インダン一1・4−ジカルボン酸
が得られる。25 Example 9 By the same operation as in Example 3, from 3.6y of 1,3-dithiane, 10ml of a 20% hexane solution of n-butyllithium, and 5.3V of 1-oxoindan-4-carboxylic acid methyl ester , indane-1,4-dicarboxylic acid is obtained.
融点245.5一248℃(再結晶溶媒:アセトン)元
素分析値 CllHlOO4
計算値 C64.O7;H4.89
実験値 C64、05;H4.73Melting point 245.5-248°C (recrystallization solvent: acetone) Elemental analysis value CllHlOO4 Calculated value C64. O7; H4.89 Experimental value C64,05; H4.73
Claims (1)
、低級アルコキシカルボニル基または置換基として低級
アルキルまたはハロゲン原子を有していてもよいベンゾ
イル基を示す。 〕で表わされる化合物を水または低級脂肪族アルコール
の存在下に加溶媒分解することを特徴とする一般式▲数
式、化学式、表等があります▼〔式中、nおよびAは前
記と同意義であり、Rは水素原子または低級アルキル基
を示す。 〕で表わされる化合物の製造法。2 一般式 ▲数式、化学式、表等があります▼ 〔式中、nは1または2の整数を、Aはカルボキシル基
、低級アルコキシカルボニル基または置換基として低級
アルキルまたはハロゲン原子を有していてもよいベンゾ
イル基を示す。 〕で表わされる化合物と1・3−ジチアンとを塩基の存
在下で反応させ、生成する一般式▲数式、化学式、表等
があります▼ 〔式中、nおよびAは前記と同意義。 〕で表わされる化合物を脱水し、生成する一般式▲数式
、化学式、表等があります▼ 〔式中、nおよびAは前記と同意義。 〕で表わされる化合物を水または低級脂肪族アルコール
の存在下に加溶媒分解することを特徴とする一般式▲数
式、化学式、表等があります▼〔式中、nおよびAは前
記と同意義であり、Rは水素原子または低級アルキル基
を示す。 〕で表わされる化合物の製造法。[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, n is an integer of 1 or 2, and A is a carboxyl group, a lower alkoxycarbonyl group, or a lower alkyl or halogen atom as a substituent. Indicates a benzoyl group which may have. ] A general formula characterized by solvolyzing a compound represented by the following in the presence of water or a lower aliphatic alcohol ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, n and A have the same meanings as above. , and R represents a hydrogen atom or a lower alkyl group. ] A method for producing a compound represented by 2 General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. Shows good benzoyl group. ] The general formula produced by reacting the compound represented by 1,3-dithiane with 1,3-dithiane in the presence of a base ▲ There are numerical formulas, chemical formulas, tables, etc. ▼ [In the formula, n and A have the same meanings as above. ] The general formula produced by dehydrating the compound represented by ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, n and A have the same meanings as above. ] A general formula characterized by solvolyzing a compound represented by the following in the presence of water or a lower aliphatic alcohol ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [In the formula, n and A have the same meanings as above. , and R represents a hydrogen atom or a lower alkyl group. ] A method for producing a compound represented by
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5103474A JPS5912097B2 (en) | 1974-05-07 | 1974-05-07 | Method for producing cyclic compounds |
| CA205,943A CA1048041A (en) | 1973-08-11 | 1974-07-30 | Benzalicyclic carboxylic acid derivatives |
| FR7427644A FR2257282B1 (en) | 1973-08-11 | 1974-08-08 | |
| FI2361/74A FI59788C (en) | 1973-08-11 | 1974-08-08 | FOERFARANDE FOER FRAMSTAELLNING AV SOM FEBERNEDSAETTANDE SMAERTSTILLANDE OCH INFLAMMATION MOTVERKANDE MEDEL ANVAENDBARA 4-BENZOYL-INDAN-1-KARBOXYLSYRAFOERENINGAR |
| DK424874AA DK139514B (en) | 1973-08-11 | 1974-08-09 | Analogous process for the preparation of indane-1-carboxylic acid derivatives. |
| GB35171/74A GB1480231A (en) | 1973-08-11 | 1974-08-09 | Benzalicyclic carboxylic acid derivatives |
| NL7410752A NL7410752A (en) | 1973-08-11 | 1974-08-09 | PROCESS FOR PREPARING NEW BENZO-CYCLO-ALIPHATIC CARBONIC ACID DERIVATIVES. |
| CH984077A CH609666A5 (en) | 1973-09-13 | 1974-08-09 | Process for the preparation of indan- and tetrahydronaphthalene carboxylic acids |
| NO742873A NO143573C (en) | 1973-08-11 | 1974-08-09 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY INDAN-1-CARBOXYLIC ACID DERIVATIVES |
| BE147478A BE818698A (en) | 1973-08-11 | 1974-08-09 | BENZALICYCLIC CARBOXYLIC ACID DERIVATIVES |
| HUTA001317 HU170341B (en) | 1973-08-11 | 1974-08-09 | |
| DE19742438380 DE2438380C2 (en) | 1973-08-11 | 1974-08-09 | 4-Benzoylindan-1-carboxylic acids, 4-Benzylindan-1-carboxylic acids, 4-Benzoylindan-1-carbonitriles, 4-Benzoylindan-1-ones, 1-Carbamoylindan-4-carboxylic acid, 1-Cyano-indane-4-carboxylic acid and functional derivatives of carboxylic acids |
| GB488577A GB1480232A (en) | 1973-08-11 | 1974-08-09 | Carboxylic diketones |
| US05/496,855 US3953500A (en) | 1973-08-11 | 1974-08-12 | Benzalicyclic carboxylic acid derivative |
| NO751045A NO145573C (en) | 1973-08-11 | 1975-03-25 | INTERMEDIATE FOR USE IN THE PREPARATION OF THERAPEUTIC EFFECTIVE INDAN-1-CARBOXYLIC ACID DERIVATIVES |
| US05/647,810 US4007225A (en) | 1973-08-11 | 1976-01-09 | 4-Benzoylindan-1-carboxamide and derivatives thereof |
| US05/742,111 US4111997A (en) | 1973-08-11 | 1976-11-15 | Benzalicyclic carboxylic acid derivative |
| CA319,616A CA1078871A (en) | 1973-08-11 | 1979-01-15 | Benzalicyclic compounds and their production |
| CH243279A CH616140A5 (en) | 1973-08-11 | 1979-03-14 | Process for the preparation of indan- and tetrahydronaphthalene-carboxamides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5103474A JPS5912097B2 (en) | 1974-05-07 | 1974-05-07 | Method for producing cyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS50148342A JPS50148342A (en) | 1975-11-27 |
| JPS5912097B2 true JPS5912097B2 (en) | 1984-03-21 |
Family
ID=12875509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5103474A Expired JPS5912097B2 (en) | 1973-08-11 | 1974-05-07 | Method for producing cyclic compounds |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5912097B2 (en) |
-
1974
- 1974-05-07 JP JP5103474A patent/JPS5912097B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS50148342A (en) | 1975-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4161538A (en) | Substituted phenylacetic acid derivatives and process for the preparation thereof | |
| JPS59196839A (en) | Phenylacetic acid derivative | |
| CA1060039A (en) | Derivatives of 3-benzoyl-phenyl-alkanoic and alkenoic acids | |
| JPS5829950B2 (en) | Cyclic iminocarboxylic acid derivatives and their salts | |
| EP0349902A2 (en) | Processes for the preparation of morniflumate and analogous compounds | |
| JPS5912097B2 (en) | Method for producing cyclic compounds | |
| JPH10502050A (en) | N-[{4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl} carbonyl] amino acids useful in the treatment of osteoarthritis | |
| EP0155524A1 (en) | -Omega-aryl-alkylthienyl compounds, process for their preparation and pharmaceutical products containing these compounds | |
| JPS584699B2 (en) | Substituted phenylacetic acid derivatives and their production method | |
| JP3207017B2 (en) | Method for producing benzylsuccinic acid derivative and intermediate for producing the same | |
| JPS58105939A (en) | Substituted phenylacetic acid derivative and its preparation | |
| JP3207018B2 (en) | Method for producing benzylsuccinic acid derivative and intermediate for producing the same | |
| JPS599536B2 (en) | Kanjiyouka Gobutsuno Seizouhou | |
| JPH0378384B2 (en) | ||
| JPH0399084A (en) | Separating agent for organic compound | |
| KR840000961B1 (en) | Process for the preparation of cyclic carboxylic acid derivative | |
| JPS6157313B2 (en) | ||
| JPS6234034B2 (en) | ||
| JPS5838416B2 (en) | Kanjiyoukagobutsunoseizouhou | |
| JPH0780812B2 (en) | Azulene derivative thromboxane synthetase inhibitor and process for producing the same | |
| US3835146A (en) | Substituted fusaric acid derivatives | |
| JPS6237623B2 (en) | ||
| JPS5951939B2 (en) | Method for producing isoindolinone derivatives | |
| US3314974A (en) | Thienyl-1-naphthalene acetic acids and related compounds | |
| KR920000909B1 (en) | New salicylates and their salts and pharmaceutical compositions comprising them and their preparation |